RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Howard Hughes Medical Institute · University of California, San Francisco · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,811
total citations
- FWCI
- 77.31
- Percentile
- 100%
- References
- 26
Citations per year
Authors
5- PIPoulikos I. PoulikakosCorresponding
- CZChao Zhang
Howard Hughes Medical Institute, University of California, San Francisco
- GBGideon Bollag
Plexxikon (United States)
- KMKevan M. Shokat
University of California, San Francisco, Howard Hughes Medical Institute
- NRNeal Rosen
Memorial Sloan Kettering Cancer Center
Topics & keywords
Topics
Keywords
- Transactivation
- MAPK/ERK pathway
- Kinase
- Vemurafenib
- Cancer research
- Protein kinase A
- Mutant
- Chemistry
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.